IPO registrations (S-1, F-1) · Registrants

SUPERNUS PHARMACEUTICALS, INC.

SEC CIK

1356576 · filings on EDGAR ↗

Name on the registration

SUPERNUS PHARMACEUTICALS INC

Former names

SUPERNUS PHARMACEUTICALS INC (2006–2019)

Registration

Form S-1, first filed 2010-12-23, last 2012-11-28; 2 initial registrations, 9 amendments

Outcome

Final prospectus filed 2012-05-02; declared effective 2012-04-30

Industry (SIC)

Pharmaceutical Preparations 2834

Incorporated in

DE

Business address

9715 KEY WEST AVENUE, Rockville, MD 20850

EDGAR entity type

operating

Insiders and CEO pay

SUPERNUS PHARMACEUTICALS, INC. on the corporate pages

Offering terms

Final price

$5.00 per share (424B4 filed 2012-05-02, an initial public offering)

Shares sold

10,000,000

Gross proceeds

$50,000,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol SUPN

Lead underwriters

Citigroup; Piper Sandler

Syndicate

Cowen; Stifel

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: Supernus Pharmaceuticals, Inc. Fuzzy (name and state)
• Business registration: Supernus Pharmaceuticals, Inc. Fuzzy (name and state)
• Business registration: Supernus Pharmaceuticals, Inc. Fuzzy (name and state)
• Business registration: SUPERNUS PHARMACEUTICALS, INC. Fuzzy (name and state)
• Business registration: SUPERNUS PHARMACEUTICALS, INC. Fuzzy (name and state)
• Business registration: SUPERNUS PHARMACEUTICALS, INC. Fuzzy (name and state)
• Federal award recipient: SUPERNUS PHARMACEUTICALS, INC Fuzzy (name and state)
• Form D issuer: SUPERNUS PHARMACEUTICALS INC EXACT (CIK (EXACT))
• Lobbying client: SUPERNUS PHARMACEUTICALS INC Fuzzy (name and state)
• SEC filer: SUPERNUS PHARMACEUTICALS INC EXACT (CIK (EXACT))
• Person page: Krishna Kittu Kolluri Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
• Person page: Timothy C Dec Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))

Filings 15

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MD first:

• NORTHWEST BIOTHERAPEUTICS INC MD
• UNITED THERAPEUTICS Corp MD
• INTERCELL USA, INC. MD
• MACROGENICS INC MD
• MiddleBrook Pharmaceuticals, Inc. MD
• AVALON PHARMACEUTICALS INC MD
• IGC Pharma, Inc. MD
• CNBX Pharmaceuticals Inc. MD
• PRECIGEN, INC. MD
• Sucampo Pharmaceuticals, Inc. MD

More with this interest.

In other datasets, the same topic (Health) in MD:

• Nonprofit: 4K FOR CANCER INC (Nonprofits (IRS Form 990))

Interests: Pharmaceutical Preparations · Health